8049 — Jilin Province Huinan Changlong Bio-pharmacy Co Income Statement
0.000.00%
Last trade - 00:00- HK$1.32bn
- HK$543.71m
- CNY901.87m
Annual income statement for Jilin Province Huinan Changlong Bio-pharmacy Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 705 | 842 | 842 | 881 | 902 |
| Cost of Revenue | |||||
| Gross Profit | 580 | 648 | 584 | 685 | 758 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 528 | 644 | 643 | 672 | 636 |
| Operating Profit | 178 | 198 | 199 | 209 | 266 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 177 | 197 | 198 | 207 | 264 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 143 | 194 | 148 | 184 | 199 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 143 | 194 | 148 | 184 | 199 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 143 | 194 | 148 | 184 | 199 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.256 | 0.373 | 0.272 | 0.329 | 0.354 |
| Special Dividends per Share |